Skip to main content
logo
Pharmaids Pharmaceuticals Limited (BOM:524572)
India flag India · Delayed Price · Currency is INR
30.09
-0.12 (-0.40%)
At close: Sep 10, 2026

Pharmaids Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
253.4278.82194.47151.12-39.39
Revenue Growth
18.52%43.37%28.69%---53.93%
Gross Profit
100.7699.6457.8526.02-9.043.68
Operating Income
-107.79-155.59-151.75-140.2-99.081.28
Net Income
-45.6-117.17-107.77-79.68-75.561.45
Earnings Per Share
-2.29-3.32-3.06-3.51-5.860.14
EPS Growth
-----55.56%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.341.338.2348.04160.594.07
Total Debt
233.82265.38420.27115.33--
Net Cash (Debt)
-232.49-264.05-412.04-67.29160.594.07
Net Cash Growth
----3841.48%103.44%
Net Cash Per Share
-11.70-7.49-11.68-2.9612.450.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--40.57-151.13-106.2-40.19-2.59
Capital Expenditures
--44.72-124.81-228.63-16.73-
Free Cash Flow
--85.29-275.94-334.82-56.92-2.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
39.76%35.73%29.75%17.21%-9.34%
Operating Margin
-42.54%-55.80%-78.03%-92.77%-3.25%
Pretax Margin
-26.51%-58.47%-88.85%-103.37%-3.56%
Profit Margin
-18.00%-42.02%-55.41%-52.73%-3.69%
FCF Margin
--30.59%-141.89%-221.56%--6.58%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-----88.87
PS Ratio
4.223.5012.4512.14-3.28